Quantitative Proteomics Identifies the Myb-Binding Protein p160 as a Novel Target of the von Hippel-Lindau Tumor Suppressor
2011

Identifying p160 as a Target of the VHL Tumor Suppressor

publication Evidence: moderate

Author Information

Author(s): Lai Yan, Qiao Mei, Song Meihua, Weintraub Susan T., Shiio Yuzuru

Primary Institution: Greehey Children's Cancer Research Institute, San Antonio, Texas, United States of America

Hypothesis

Can quantitative proteomics identify novel substrates of the VHL tumor suppressor?

Conclusion

The study identified the Myb-binding protein p160 as a novel substrate of the VHL tumor suppressor, which is degraded in an iron-dependent manner.

Supporting Evidence

  • The study confirmed that p160 is upregulated when VHL is not functional.
  • VHL was shown to directly bind and degrade p160.
  • Degradation of p160 by VHL requires iron, similar to the regulation of HIF.

Takeaway

Researchers found that a protein called p160 is broken down by a tumor suppressor called VHL, which helps control cancer growth.

Methodology

The study used quantitative proteomics to identify VHL substrates by comparing protein expression in cells with and without functional VHL.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016975

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication